Revolutionizing Behavioral Health Research Through Philanthropy
The Vail Health Behavioral Health Innovation Center is ushering in a new era of behavioral health research, treatment, and education.
A Conversation with Chloe Sorensen
Learn more about Chloe Sorensen, Clinical Research Supervisor at the Vail Health Behavioral Health Innovation Center.
Vail Health’s Pioneering Study of Psilocybin’s Effects on Depression Kicks off Next Month
(Vail Daily) In April, Vail Health’s Behavioral Health Innovation Center will kick off the second of two studies aimed at targeting depression. The OPTIMIZE study will examine the impacts of psilocybin, the active ingredient in psychedelic mushrooms, on people with major depressive disorder.
OPTIMIZE Study to Examine Impact of Psilocybin on Depression
The OPTIMIZE Study will explore innovative methods to amplify the effects of psilocybin on depression and anxiety through the co-administration of non-invasive vagus nerve stimulation.
Unlocking the Mysteries of Consciousness Featuring Christof Koch, PhD, an Innovations in Health Learning Lab
Join us for an enlightening talk by neuroscientist and the pioneer of consciousness research Christof Koch, PhD, as he explores transformative experiences like mystical encounters, near-death experiences, and psychedelic journeys.